23,99 €
inkl. MwSt.

Versandfertig in über 4 Wochen
payback
12 °P sammeln
  • Broschiertes Buch

This Element analyses the tension between innovation and financialisation in the UK pharmaceutical industry, focusing on AstraZeneca and GlaxoSmithKline. This title is also available as Open Access on Cambridge Core.

Produktbeschreibung
This Element analyses the tension between innovation and financialisation in the UK pharmaceutical industry, focusing on AstraZeneca and GlaxoSmithKline. This title is also available as Open Access on Cambridge Core.